Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Kane

Showing results (901-910 of 1,451) with videos related to

Pageof 146
Sort By:
Neurotoxicology and Teratology|July 13, 2021
Ethanol modulation of hippocampal neuroinflammation, myelination, and neurodevelopment in a postnatal mouse model of fetal alcohol spectrum disordersVictoria M Niedzwiedz-Massey, James C Douglas, Tonya Rafferty, et al.
Neuropsychiatric Disease and Treatment|June 21, 2018
Initiating/maintaining long-acting injectable antipsychotics in schizophrenia/schizoaffective or bipolar disorder - expert consensus survey part 2Martha Sajatovic, Ruth Ross, Susan N Legacy, et al.
Psychiatric Services (Washington, D.C.)|May 16, 2019
Predictors of Hospitalization of Individuals With First-Episode Psychosis: Data From a 2-Year Follow-Up of the RAISE-ETPDelbert G Robinson, Nina R Schooler, Robert A Rosenheck, et al.
Medecine Tropicale : Revue Du Corps De Sante Colonial|February 10, 2006
[Epidemiological aspects of stroke in CT-scan department of the Point-G Hospital in Bamako, Mali]A D Keita, M Toure, A Diawara, et al.
Preventive Medicine|January 1, 1994
An evaluation of the relationship between self-report and biochemical measures of environmental tobacco smoke exposureK M Emmons, D B Abrams, R Marshall, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|October 1, 1994
Methylphenidate response, psychopathology and tardive dyskinesia as predictors of relapse in schizophreniaJ A Lieberman, J Alvir, S Geisler, et al.
Journal of Child and Adolescent Psychopharmacology|September 2, 2008
Clozapine versus "high-dose" olanzapine in refractory early-onset schizophrenia: an open-label extension studySanjiv Kumra, Harvey Kranzler, Ginny Gerbino-Rosen, et al.
Schizophrenia Research|July 5, 2014
Efficacy and safety of aripiprazole in Chinese Han schizophrenia subjects: a randomized, double-blind, active parallel-controlled, multicenter clinical trialHuafang Li, Jianfeng Luo, Chuanyue Wang, et al.
Journal of Cardiovascular Translational Research|August 3, 2012
Derivation of vascular endothelial cells from human embryonic stem cells under GMP-compliant conditions: towards clinical studies in ischaemic diseaseA Kaupisch, L Kennedy, V Stelmanis, et al.
Neuropsychiatric Disease and Treatment|June 21, 2018
Identifying patients and clinical scenarios for use of long-acting injectable antipsychotics - expert consensus survey part 1Martha Sajatovic, Ruth Ross, Susan N Legacy, et al.
Pageof 146

Showing results (901-910 of 1,451) with videos related to

Sort By:
Pageof 146
Neurotoxicology and Teratology|July 13, 2021
Ethanol modulation of hippocampal neuroinflammation, myelination, and neurodevelopment in a postnatal mouse model of fetal alcohol spectrum disordersVictoria M Niedzwiedz-Massey, James C Douglas, Tonya Rafferty, et al.
Neuropsychiatric Disease and Treatment|June 21, 2018
Initiating/maintaining long-acting injectable antipsychotics in schizophrenia/schizoaffective or bipolar disorder - expert consensus survey part 2Martha Sajatovic, Ruth Ross, Susan N Legacy, et al.
Psychiatric Services (Washington, D.C.)|May 16, 2019
Predictors of Hospitalization of Individuals With First-Episode Psychosis: Data From a 2-Year Follow-Up of the RAISE-ETPDelbert G Robinson, Nina R Schooler, Robert A Rosenheck, et al.
Medecine Tropicale : Revue Du Corps De Sante Colonial|February 10, 2006
[Epidemiological aspects of stroke in CT-scan department of the Point-G Hospital in Bamako, Mali]A D Keita, M Toure, A Diawara, et al.
Preventive Medicine|January 1, 1994
An evaluation of the relationship between self-report and biochemical measures of environmental tobacco smoke exposureK M Emmons, D B Abrams, R Marshall, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|October 1, 1994
Methylphenidate response, psychopathology and tardive dyskinesia as predictors of relapse in schizophreniaJ A Lieberman, J Alvir, S Geisler, et al.
Journal of Child and Adolescent Psychopharmacology|September 2, 2008
Clozapine versus "high-dose" olanzapine in refractory early-onset schizophrenia: an open-label extension studySanjiv Kumra, Harvey Kranzler, Ginny Gerbino-Rosen, et al.
Schizophrenia Research|July 5, 2014
Efficacy and safety of aripiprazole in Chinese Han schizophrenia subjects: a randomized, double-blind, active parallel-controlled, multicenter clinical trialHuafang Li, Jianfeng Luo, Chuanyue Wang, et al.
Journal of Cardiovascular Translational Research|August 3, 2012
Derivation of vascular endothelial cells from human embryonic stem cells under GMP-compliant conditions: towards clinical studies in ischaemic diseaseA Kaupisch, L Kennedy, V Stelmanis, et al.
Neuropsychiatric Disease and Treatment|June 21, 2018
Identifying patients and clinical scenarios for use of long-acting injectable antipsychotics - expert consensus survey part 1Martha Sajatovic, Ruth Ross, Susan N Legacy, et al.
Pageof 146